EUVIMEDEUVIMED entdecken
Crossref

Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance

Arpita Jha, Manzar Alam, Tanushree Kashyap, Nidhi Nath, Anjali Kumari, Kamdeo K Pramanik, Siddavaram Nagini, Rajakishore Mishra

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Arpita Jha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Cheri-Manatu, Kanke, Ranchi 835 222, Jharkhand, India. Hauptthemen laut MEDLINE: B7-H1 Antigen, Mouth Neoplasms, Janus Kinase 2. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Central University of Jharkhand, Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Programmed cell death ligand-1 (PD-L1)is an antitumor immunity molecule and a great target to cure oral cancer; nonetheless, the limited success can be attributed to many complex pathways and tumor-related interferences. METHODS: In the present study, 150 human oral squamous cell carcinoma (OSCC) tissue samples, including 17 adjacent normals, 56 primary tumors, 47 invasive tumors, and 30 therapy-resistant (RT) samples, were included. The parental/cisplatin-resistant (CisR-SCC4/9) cells were utilized for overexpression (Jak1-3 wild type and catalytically inactive), knockdown (PD-L1 siRNA), targeting MAPK/PI3K/Jak-Stat pathways (SMIs) and checking microsomes. The expression of PD-L1, transcription factors (TFs), signaling pathways, survival/apoptosis, therapy resistance, and invasiveness-related molecules/their activity were determined by RT-PCR, Immunohistochemistry, Western blot, Gelatin Zymography, and MTT assay. RESULTS: Advanced OSCC tumors (invasive and drug-resistance), CisR-SCC4/9 cells, and secretory exosomes (CisR-SCC4/9) were found with increased PD-L1 expression. PD-L1 mRNA/protein showed a positive correlation with different TFs (AP1 > Stat3 > c-myc > NFκB) in tumor samples. The PD-L1 expression was more influenced by Jak-Stat/ MAPK-AP1 pathways over PI3K. The ectopic expression of Jak1-3 suggests Jak2 inducted PD-L1 level over Jak1/Jak3. Finally, PD-L1 directly supports survival (Bcl-xL, Bax, cleaved caspase-3), invasion (MMP2/9), and drug-resistance (ALDH-1A1/-3A1) program in OSCC through its link with several molecules. CONCLUSIONS: PD-L1 was regulated mainly by the Jak2-Stat3/ MAPK-AP1 pathway, and besides the routine immunological functions, it supports OSCC survival, invasion, and therapy resistance. PD-L1 can be used as an indicator of severity and can be targeted along with Jak2-Stat3/ MAPK-AP1 for a better outcome OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenMouth NeoplasmsJanus Kinase 2HumansSTAT3 Transcription FactorDrug Resistance, NeoplasmCell Line, TumorSignal TransductionNeoplasm InvasivenessTranscription Factor AP-1FemaleMaleMiddle AgedDisease ProgressionApoptosis

Stichwörter der Autor:innen

Drug-resistanceInvasivenessJak2-Stat3MAPK-AP1MMP2/9Oral cancerPD-L1Transcription factor

Substanzen

B7-H1 AntigenSTAT3 Transcription FactorCD274 protein, humanJanus Kinase 2JAK2 protein, humanSTAT3 protein, humanTranscription Factor AP-1

Autor:innen und Institutionen

  • Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Cheri-Manatu, Kanke, Ranchi 835 222, Jharkhand, India.
  • Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamil Nadu, India.
  • Department of Life Sciences, School of Natural Sciences, Central University of Jharkhand, Cheri-Manatu, Kanke, Ranchi 835 222, Jharkhand, India. Electronic address: rajakishore.mishra@cuj.ac.in.

Förderung

  • Central University of Jharkhand
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Jha, A., Alam, M., Kashyap, T., Nath, N., Kumari, A., Pramanik, K. K., Nagini, S., & Mishra, R. (2023). Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110894

Vancouver

Jha A, Alam M, Kashyap T, Nath N, Kumari A, Pramanik KK, et al. Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110894

BibTeX
@article{Jha2023,
  author = {Jha, Arpita and Alam, Manzar and Kashyap, Tanushree and Nath, Nidhi and Kumari, Anjali and Pramanik, Kamdeo K and Nagini, Siddavaram and Mishra, Rajakishore},
  title = {Crosstalk between PD-L1 and Jak2-Stat3/ MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110894}
}
Kostenlos starten →